APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioactive Protein and Peptides

Compare research editions
View pricing & licenses

Selected research

Industry Research

Bioactive Protein and Peptides Industry Research Report 2026

13 August 2026132 pages

Choose your research edition.

Industry ResearchBioactive Protein and Peptides Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioactive Protein and Peptides Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Bioactive Protein and Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioactive Protein and Peptides Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioactive Protein and Peptides Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Bioactive Protein and Peptides market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Bioactive Protein and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Bioactive Protein and Peptides is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Bioactive Protein and Peptides is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Bioactive Protein and Peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, Bunge Ltd, Ingredia Nutritional, Gelatines Weishardt and PanTheryx, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Bioactive Protein and Peptides market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Bioactive Protein and Peptides Market by Company

Gelita

Kerry Group

Vital Proteins

Rousselot

BRF Ingredients

Bunge Ltd

Ingredia Nutritional

Gelatines Weishardt

PanTheryx

Hubei Reborn Biotech

Seagarden

Shandong Hengxin Biotech

Baotou Dongbao Bio-Tech

Wuhan Jiushengtang Biotech

Morinaga Milk

Collagile

Nuritas

SmartPEP

Bioactive Protein and Peptides Segment by Type

Plant Source

Animal Source

Bioactive Protein and Peptides Segment by Application

Functional Food

Dietary Supplements

Personal Care

Animal Nutrition

Other

Bioactive Protein and Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioactive Protein and Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioactive Protein and Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioactive Protein and Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Bioactive Protein and Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Bioactive Protein and Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Bioactive Protein and Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Bioactive Protein and Peptides Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Bioactive Protein and Peptides Sales (k units) of Manufacturers (2021-2026) Table 7. Global Bioactive Protein and Peptides Sales Market Share by Manufacturers (2021-2026) Table 8. Global Bioactive Protein and Peptides Revenue of Manufacturers (2021-2026) Table 9. Global Bioactive Protein and Peptides Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Bioactive Protein and Peptides Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Bioactive Protein and Peptides Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Bioactive Protein and Peptides, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Bioactive Protein and Peptides, Product Type & Application Table 14. Global Bioactive Protein and Peptides Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Bioactive Protein and Peptides by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Gelita Company Information Table 19. Gelita Business Overview Table 20. Gelita Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Gelita Bioactive Protein and Peptides Product Portfolio Table 22. Gelita Recent Developments Table 23. Kerry Group Company Information Table 24. Kerry Group Business Overview Table 25. Kerry Group Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Kerry Group Bioactive Protein and Peptides Product Portfolio Table 27. Kerry Group Recent Developments Table 28. Vital Proteins Company Information Table 29. Vital Proteins Business Overview Table 30. Vital Proteins Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Vital Proteins Bioactive Protein and Peptides Product Portfolio Table 32. Vital Proteins Recent Developments Table 33. Rousselot Company Information Table 34. Rousselot Business Overview Table 35. Rousselot Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Rousselot Bioactive Protein and Peptides Product Portfolio Table 37. Rousselot Recent Developments Table 38. BRF Ingredients Company Information Table 39. BRF Ingredients Business Overview Table 40. BRF Ingredients Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. BRF Ingredients Bioactive Protein and Peptides Product Portfolio Table 42. BRF Ingredients Recent Developments Table 43. Bunge Ltd Company Information Table 44. Bunge Ltd Business Overview Table 45. Bunge Ltd Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Bunge Ltd Bioactive Protein and Peptides Product Portfolio Table 47. Bunge Ltd Recent Developments Table 48. Ingredia Nutritional Company Information Table 49. Ingredia Nutritional Business Overview Table 50. Ingredia Nutritional Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Ingredia Nutritional Bioactive Protein and Peptides Product Portfolio Table 52. Ingredia Nutritional Recent Developments Table 53. Gelatines Weishardt Company Information Table 54. Gelatines Weishardt Business Overview Table 55. Gelatines Weishardt Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Gelatines Weishardt Bioactive Protein and Peptides Product Portfolio Table 57. Gelatines Weishardt Recent Developments Table 58. PanTheryx Company Information Table 59. PanTheryx Business Overview Table 60. PanTheryx Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. PanTheryx Bioactive Protein and Peptides Product Portfolio Table 62. PanTheryx Recent Developments Table 63. Hubei Reborn Biotech Company Information Table 64. Hubei Reborn Biotech Business Overview Table 65. Hubei Reborn Biotech Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Hubei Reborn Biotech Bioactive Protein and Peptides Product Portfolio Table 67. Hubei Reborn Biotech Recent Developments Table 68. Seagarden Company Information Table 69. Seagarden Business Overview Table 70. Seagarden Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Seagarden Bioactive Protein and Peptides Product Portfolio Table 72. Seagarden Recent Developments Table 73. Shandong Hengxin Biotech Company Information Table 74. Shandong Hengxin Biotech Business Overview Table 75. Shandong Hengxin Biotech Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Shandong Hengxin Biotech Bioactive Protein and Peptides Product Portfolio Table 77. Shandong Hengxin Biotech Recent Developments Table 78. Baotou Dongbao Bio-Tech Company Information Table 79. Baotou Dongbao Bio-Tech Business Overview Table 80. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Product Portfolio Table 82. Baotou Dongbao Bio-Tech Recent Developments Table 83. Wuhan Jiushengtang Biotech Company Information Table 84. Wuhan Jiushengtang Biotech Business Overview Table 85. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Product Portfolio Table 87. Wuhan Jiushengtang Biotech Recent Developments Table 88. Morinaga Milk Company Information Table 89. Morinaga Milk Business Overview Table 90. Morinaga Milk Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Morinaga Milk Bioactive Protein and Peptides Product Portfolio Table 92. Morinaga Milk Recent Developments Table 93. Collagile Company Information Table 94. Collagile Business Overview Table 95. Collagile Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Collagile Bioactive Protein and Peptides Product Portfolio Table 97. Collagile Recent Developments Table 98. Nuritas Company Information Table 99. Nuritas Business Overview Table 100. Nuritas Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Nuritas Bioactive Protein and Peptides Product Portfolio Table 102. Nuritas Recent Developments Table 103. SmartPEP Company Information Table 104. SmartPEP Business Overview Table 105. SmartPEP Bioactive Protein and Peptides Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. SmartPEP Bioactive Protein and Peptides Product Portfolio Table 107. SmartPEP Recent Developments Table 108. Global Bioactive Protein and Peptides Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Bioactive Protein and Peptides Sales by Region (2021-2026) & (k units) Table 110. Global Bioactive Protein and Peptides Sales Market Share by Region (2021-2026) Table 111. Global Bioactive Protein and Peptides Sales by Region (2027-2032) & (k units) Table 112. Global Bioactive Protein and Peptides Sales Market Share by Region (2027-2032) Table 113. Global Bioactive Protein and Peptides Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Bioactive Protein and Peptides Revenue Market Share by Region (2021-2026) Table 115. Global Bioactive Protein and Peptides Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Bioactive Protein and Peptides Revenue Market Share by Region (2027-2032) Table 117. North America Bioactive Protein and Peptides Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Bioactive Protein and Peptides Sales by Country (2021-2026) & (k units) Table 119. North America Bioactive Protein and Peptides Sales by Country (2027-2032) & (k units) Table 120. North America Bioactive Protein and Peptides Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Bioactive Protein and Peptides Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Bioactive Protein and Peptides Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Bioactive Protein and Peptides Sales by Country (2021-2026) & (k units) Table 124. Europe Bioactive Protein and Peptides Sales by Country (2027-2032) & (k units) Table 125. Europe Bioactive Protein and Peptides Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Bioactive Protein and Peptides Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Bioactive Protein and Peptides Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Bioactive Protein and Peptides Sales by Country (2021-2026) & (k units) Table 129. Asia Pacific Bioactive Protein and Peptides Sales by Country (2027-2032) & (k units) Table 130. Asia Pacific Bioactive Protein and Peptides Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Bioactive Protein and Peptides Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Bioactive Protein and Peptides Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Bioactive Protein and Peptides Sales by Country (2021-2026) & (k units) Table 134. South America Bioactive Protein and Peptides Sales by Country (2027-2032) & (k units) Table 135. South America Bioactive Protein and Peptides Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Bioactive Protein and Peptides Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Bioactive Protein and Peptides Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Bioactive Protein and Peptides Sales by Country (2021-2026) & (k units) Table 139. Middle East and Africa Bioactive Protein and Peptides Sales by Country (2027-2032) & (k units) Table 140. Middle East and Africa Bioactive Protein and Peptides Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Bioactive Protein and Peptides Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Bioactive Protein and Peptides Sales by Type (2021-2026) & (k units) Table 143. Global Bioactive Protein and Peptides Sales by Type (2027-2032) & (k units) Table 144. Global Bioactive Protein and Peptides Sales Market Share by Type (2021-2026) Table 145. Global Bioactive Protein and Peptides Sales Market Share by Type (2027-2032) Table 146. Global Bioactive Protein and Peptides Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Bioactive Protein and Peptides Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Bioactive Protein and Peptides Revenue Market Share by Type (2021-2026) Table 149. Global Bioactive Protein and Peptides Revenue Market Share by Type (2027-2032) Table 150. Global Bioactive Protein and Peptides Price by Type (2021-2026) & (USD/unit) Table 151. Global Bioactive Protein and Peptides Price by Type (2027-2032) & (USD/unit) Table 152. Global Bioactive Protein and Peptides Sales by Application (2021-2026) & (k units) Table 153. Global Bioactive Protein and Peptides Sales by Application (2027-2032) & (k units) Table 154. Global Bioactive Protein and Peptides Sales Market Share by Application (2021-2026) Table 155. Global Bioactive Protein and Peptides Sales Market Share by Application (2027-2032) Table 156. Global Bioactive Protein and Peptides Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Bioactive Protein and Peptides Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Bioactive Protein and Peptides Revenue Market Share by Application (2021-2026) Table 159. Global Bioactive Protein and Peptides Revenue Market Share by Application (2027-2032) Table 160. Global Bioactive Protein and Peptides Price by Application (2021-2026) & (USD/unit) Table 161. Global Bioactive Protein and Peptides Price by Application (2027-2032) & (USD/unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Bioactive Protein and Peptides Distributors List Table 165. Bioactive Protein and Peptides Customers List Table 166. Bioactive Protein and Peptides Industry Trends Table 167. Bioactive Protein and Peptides Industry Drivers Table 168. Bioactive Protein and Peptides Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Bioactive Protein and Peptides Product Image Figure 5. Global Bioactive Protein and Peptides Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Bioactive Protein and Peptides Market Size (2021-2032) & (US$ Million) Figure 7. Global Bioactive Protein and Peptides Sales (2021-2032) & (k units) Figure 8. Global Bioactive Protein and Peptides Average Price (USD/unit) & (2021-2032) Figure 9. Plant Source Product Image Figure 10. Animal Source Product Image Figure 11. Functional Food Product Image Figure 12. Dietary Supplements Product Image Figure 13. Personal Care Product Image Figure 14. Animal Nutrition Product Image Figure 15. Other Product Image Figure 16. Global Bioactive Protein and Peptides Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Bioactive Protein and Peptides, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Bioactive Protein and Peptides Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Bioactive Protein and Peptides Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Bioactive Protein and Peptides Sales by Region in 2025 Figure 22. Global Bioactive Protein and Peptides Revenue by Region in 2025 Figure 23. North America Bioactive Protein and Peptides Market Size by Country in 2025 Figure 24. North America Bioactive Protein and Peptides Sales Market Share by Country (2021-2032) Figure 25. North America Bioactive Protein and Peptides Revenue Market Share by Country (2021-2032) Figure 26. United States Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Bioactive Protein and Peptides Market Size by Country in 2025 Figure 30. Europe Bioactive Protein and Peptides Sales Market Share by Country (2021-2032) Figure 31. Europe Bioactive Protein and Peptides Revenue Market Share by Country (2021-2032) Figure 32. Germany Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Bioactive Protein and Peptides Market Size by Country in 2025 Figure 43. Asia Pacific Bioactive Protein and Peptides Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Bioactive Protein and Peptides Revenue Market Share by Country (2021-2032) Figure 45. China Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Bioactive Protein and Peptides Market Size by Country in 2025 Figure 54. South America Bioactive Protein and Peptides Sales Market Share by Country (2021-2032) Figure 55. South America Bioactive Protein and Peptides Revenue Market Share by Country (2021-2032) Figure 56. Brazil Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Bioactive Protein and Peptides Market Size by Country in 2025 Figure 60. Middle East and Africa Bioactive Protein and Peptides Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Bioactive Protein and Peptides Revenue Market Share by Country (2021-2032) Figure 62. Egypt Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Bioactive Protein and Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Bioactive Protein and Peptides Sales Market Share by Type (2021-2032) Figure 68. Global Bioactive Protein and Peptides Revenue Market Share by Type (2021-2032) Figure 69. Global Bioactive Protein and Peptides Price (USD/unit) by Type (2021-2032) Figure 70. Global Bioactive Protein and Peptides Sales Market Share by Application (2021-2032) Figure 71. Global Bioactive Protein and Peptides Revenue Market Share by Application (2021-2032) Figure 72. Global Bioactive Protein and Peptides Price (USD/unit) by Application (2021-2032) Figure 73. Bioactive Protein and Peptides Value Chain Figure 74. Bioactive Protein and Peptides Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Bioactive Protein and Peptides Industry Opportunities and Challenges

Scope & coverage.

Types
  • Plant Source
  • Animal Source
Applications
  • Functional Food
  • Dietary Supplements
  • Personal Care
  • Animal Nutrition
  • Other
Companies covered
  • Gelita
  • Kerry Group
  • Vital Proteins
  • Rousselot
  • BRF Ingredients
  • Bunge Ltd
  • Ingredia Nutritional
  • Gelatines Weishardt
  • PanTheryx
  • Hubei Reborn Biotech
  • Seagarden
  • Shandong Hengxin Biotech
  • Baotou Dongbao Bio-Tech
  • Wuhan Jiushengtang Biotech
  • Morinaga Milk
  • Collagile
  • Nuritas
  • SmartPEP

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Bioactive Protein and Peptides Market Size (2021-2032)
  4. 2.2.2 Global Bioactive Protein and Peptides Sales (2021-2032)
  5. 2.2.3 Global Bioactive Protein and Peptides Market Average Price (2021-2032)
  6. 2.3 Bioactive Protein and Peptides by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Plant Source
  9. 2.3.3 Animal Source
  10. 2.4 Bioactive Protein and Peptides by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Functional Food
  13. 2.4.3 Dietary Supplements
  14. 2.4.4 Personal Care
  15. 2.4.5 Animal Nutrition
  16. 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Bioactive Protein and Peptides Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Bioactive Protein and Peptides Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Bioactive Protein and Peptides Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Bioactive Protein and Peptides Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Bioactive Protein and Peptides Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Bioactive Protein and Peptides, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Bioactive Protein and Peptides, Product Type & Application
  8. 3.8 Global Manufacturers of Bioactive Protein and Peptides, Established Date
  9. 3.9 Global Bioactive Protein and Peptides Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Gelita
  2. 4.1.1 Gelita Company Information
  3. 4.1.2 Gelita Business Overview
  4. 4.1.3 Gelita Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Gelita Bioactive Protein and Peptides Product Portfolio
  6. 4.1.5 Gelita Recent Developments
  7. 4.2 Kerry Group
  8. 4.2.1 Kerry Group Company Information
  9. 4.2.2 Kerry Group Business Overview
  10. 4.2.3 Kerry Group Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Kerry Group Bioactive Protein and Peptides Product Portfolio
  12. 4.2.5 Kerry Group Recent Developments
  13. 4.3 Vital Proteins
  14. 4.3.1 Vital Proteins Company Information
  15. 4.3.2 Vital Proteins Business Overview
  16. 4.3.3 Vital Proteins Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Vital Proteins Bioactive Protein and Peptides Product Portfolio
  18. 4.3.5 Vital Proteins Recent Developments
  19. 4.4 Rousselot
  20. 4.4.1 Rousselot Company Information
  21. 4.4.2 Rousselot Business Overview
  22. 4.4.3 Rousselot Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Rousselot Bioactive Protein and Peptides Product Portfolio
  24. 4.4.5 Rousselot Recent Developments
  25. 4.5 BRF Ingredients
  26. 4.5.1 BRF Ingredients Company Information
  27. 4.5.2 BRF Ingredients Business Overview
  28. 4.5.3 BRF Ingredients Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 BRF Ingredients Bioactive Protein and Peptides Product Portfolio
  30. 4.5.5 BRF Ingredients Recent Developments
  31. 4.6 Bunge Ltd
  32. 4.6.1 Bunge Ltd Company Information
  33. 4.6.2 Bunge Ltd Business Overview
  34. 4.6.3 Bunge Ltd Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Bunge Ltd Bioactive Protein and Peptides Product Portfolio
  36. 4.6.5 Bunge Ltd Recent Developments
  37. 4.7 Ingredia Nutritional
  38. 4.7.1 Ingredia Nutritional Company Information
  39. 4.7.2 Ingredia Nutritional Business Overview
  40. 4.7.3 Ingredia Nutritional Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Ingredia Nutritional Bioactive Protein and Peptides Product Portfolio
  42. 4.7.5 Ingredia Nutritional Recent Developments
  43. 4.8 Gelatines Weishardt
  44. 4.8.1 Gelatines Weishardt Company Information
  45. 4.8.2 Gelatines Weishardt Business Overview
  46. 4.8.3 Gelatines Weishardt Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Gelatines Weishardt Bioactive Protein and Peptides Product Portfolio
  48. 4.8.5 Gelatines Weishardt Recent Developments
  49. 4.9 PanTheryx
  50. 4.9.1 PanTheryx Company Information
  51. 4.9.2 PanTheryx Business Overview
  52. 4.9.3 PanTheryx Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 PanTheryx Bioactive Protein and Peptides Product Portfolio
  54. 4.9.5 PanTheryx Recent Developments
  55. 4.10 Hubei Reborn Biotech
  56. 4.10.1 Hubei Reborn Biotech Company Information
  57. 4.10.2 Hubei Reborn Biotech Business Overview
  58. 4.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Hubei Reborn Biotech Bioactive Protein and Peptides Product Portfolio
  60. 4.10.5 Hubei Reborn Biotech Recent Developments
  61. 4.11 Seagarden
  62. 4.11.1 Seagarden Company Information
  63. 4.11.2 Seagarden Business Overview
  64. 4.11.3 Seagarden Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Seagarden Bioactive Protein and Peptides Product Portfolio
  66. 4.11.5 Seagarden Recent Developments
  67. 4.12 Shandong Hengxin Biotech
  68. 4.12.1 Shandong Hengxin Biotech Company Information
  69. 4.12.2 Shandong Hengxin Biotech Business Overview
  70. 4.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Shandong Hengxin Biotech Bioactive Protein and Peptides Product Portfolio
  72. 4.12.5 Shandong Hengxin Biotech Recent Developments
  73. 4.13 Baotou Dongbao Bio-Tech
  74. 4.13.1 Baotou Dongbao Bio-Tech Company Information
  75. 4.13.2 Baotou Dongbao Bio-Tech Business Overview
  76. 4.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Product Portfolio
  78. 4.13.5 Baotou Dongbao Bio-Tech Recent Developments
  79. 4.14 Wuhan Jiushengtang Biotech
  80. 4.14.1 Wuhan Jiushengtang Biotech Company Information
  81. 4.14.2 Wuhan Jiushengtang Biotech Business Overview
  82. 4.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Product Portfolio
  84. 4.14.5 Wuhan Jiushengtang Biotech Recent Developments
  85. 4.15 Morinaga Milk
  86. 4.15.1 Morinaga Milk Company Information
  87. 4.15.2 Morinaga Milk Business Overview
  88. 4.15.3 Morinaga Milk Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Morinaga Milk Bioactive Protein and Peptides Product Portfolio
  90. 4.15.5 Morinaga Milk Recent Developments
  91. 4.16 Collagile
  92. 4.16.1 Collagile Company Information
  93. 4.16.2 Collagile Business Overview
  94. 4.16.3 Collagile Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Collagile Bioactive Protein and Peptides Product Portfolio
  96. 4.16.5 Collagile Recent Developments
  97. 4.17 Nuritas
  98. 4.17.1 Nuritas Company Information
  99. 4.17.2 Nuritas Business Overview
  100. 4.17.3 Nuritas Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Nuritas Bioactive Protein and Peptides Product Portfolio
  102. 4.17.5 Nuritas Recent Developments
  103. 4.18 SmartPEP
  104. 4.18.1 SmartPEP Company Information
  105. 4.18.2 SmartPEP Business Overview
  106. 4.18.3 SmartPEP Bioactive Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 SmartPEP Bioactive Protein and Peptides Product Portfolio
  108. 4.18.5 SmartPEP Recent Developments
5 Global Bioactive Protein and Peptides Market Scenario by Region
  1. 5.1 Global Bioactive Protein and Peptides Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Bioactive Protein and Peptides Sales by Region: 2021-2032
  3. 5.2.1 Global Bioactive Protein and Peptides Sales by Region: 2021-2026
  4. 5.2.2 Global Bioactive Protein and Peptides Sales by Region: 2027-2032
  5. 5.3 Global Bioactive Protein and Peptides Revenue by Region: 2021-2032
  6. 5.3.1 Global Bioactive Protein and Peptides Revenue by Region: 2021-2026
  7. 5.3.2 Global Bioactive Protein and Peptides Revenue by Region: 2027-2032
  8. 5.4 North America Bioactive Protein and Peptides Market Facts & Figures by Country
  9. 5.4.1 North America Bioactive Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Bioactive Protein and Peptides Sales by Country (2021-2032)
  11. 5.4.3 North America Bioactive Protein and Peptides Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Bioactive Protein and Peptides Market Facts & Figures by Country
  16. 5.5.1 Europe Bioactive Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Bioactive Protein and Peptides Sales by Country (2021-2032)
  18. 5.5.3 Europe Bioactive Protein and Peptides Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Bioactive Protein and Peptides Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Bioactive Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Bioactive Protein and Peptides Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Bioactive Protein and Peptides Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Bioactive Protein and Peptides Market Facts & Figures by Country
  41. 5.7.1 South America Bioactive Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Bioactive Protein and Peptides Sales by Country (2021-2032)
  43. 5.7.3 South America Bioactive Protein and Peptides Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Bioactive Protein and Peptides Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Bioactive Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Bioactive Protein and Peptides Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Bioactive Protein and Peptides Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Bioactive Protein and Peptides Sales by Type (2021-2032)
  2. 6.1.1 Global Bioactive Protein and Peptides Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Bioactive Protein and Peptides Sales Market Share by Type (2021-2032)
  4. 6.2 Global Bioactive Protein and Peptides Revenue by Type (2021-2032)
  5. 6.2.1 Global Bioactive Protein and Peptides Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Bioactive Protein and Peptides Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Bioactive Protein and Peptides Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Bioactive Protein and Peptides Sales by Application (2021-2032)
  2. 7.1.1 Global Bioactive Protein and Peptides Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Bioactive Protein and Peptides Sales Market Share by Application (2021-2032)
  4. 7.2 Global Bioactive Protein and Peptides Revenue by Application (2021-2032)
  5. 7.2.1 Global Bioactive Protein and Peptides Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Bioactive Protein and Peptides Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Bioactive Protein and Peptides Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Bioactive Protein and Peptides Value Chain Analysis
  2. 8.1.1 Bioactive Protein and Peptides Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Bioactive Protein and Peptides Production Mode & Process
  5. 8.2 Bioactive Protein and Peptides Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Bioactive Protein and Peptides Distributors
  8. 8.2.3 Bioactive Protein and Peptides Customers
9 Global Bioactive Protein and Peptides Analyzing Market Dynamics
  1. 9.1 Bioactive Protein and Peptides Industry Trends
  2. 9.2 Bioactive Protein and Peptides Industry Drivers
  3. 9.3 Bioactive Protein and Peptides Industry Opportunities and Challenges
  4. 9.4 Bioactive Protein and Peptides Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst